Clinical Study
Risk of Falls in Parkinson’s Disease: A Cross-Sectional Study of 160 Patients
Table 3
Logistic regression analysis.
| | Bivariate analysis | Multivariate analysis | | Odds ratio | 95% CI | P value | Odds ratio | 95% CI | value |
| Age | 1.04 | 0.99–1.08 | 0.025 | 1.04 | 0.95–1.14 | 0.381 | Disease duration | 1.12 | 1.05–1.19 | <0.001 | 0.96 | 0.89–1.03 | 0.326 | PD subtype | 2.37 | 1.22–4.60 | 0.010 | 2.07 | 0.89–4.80 | 0.090 | Motor fluctuations | 2.81 | 1.39–5.69 | 0.004 | 1.91 | 0.75–5.62 | 0.200 | Dyskinesia | 2.80 | 1.36–5.78 | 0.005 | 0.98 | 0.33–2.87 | 0.972 | Hoehn and Yahr | 3.06 | 2.04–4.60 | <0.001 | 1.59 | 0.72–3.50 | 0.247 | UPDRS | 1.06 | 1.03–1.09 | <0.001 | 0.98 | 0.94–1.04 | 0.658 | FOG | 4.42 | 2.24–8.72 | <0.001 | 1.65 | 0.67–4.03 | 0.274 | FOG questionnaire | 1.15 | 1.08–1.22 | <0.001 | 1.01 | 0.89–1.22 | 0.131 | Activities of daily living* | 0.96 | 0.94–0.97 | <0.001 | 1.02 | 0.92–1.14 | 0.807 | MMSE* | 0.91 | 0.85–0.98 | 0.017 | 1.02 | 0.93–1.13 | 0.640 | Tinetti Balance* | 0.80 | 0.74–0.86 | <0.001 | 0.84 | 0.74–0.97 | 0.017 | Tinetti Gait* | 0.80 | 0.73–0.87 | <0.001 | 1.13 | 0.95–1.43 | 0.256 | Tinetti total* | 0.89 | 0.85–0.93 | <0.001 | 0.93 | 0.87–1.01 | 0.690 | Get-up-and-go | 0.95 | 0.90–1.01 | 0.189 | | | | Levodopa dose | 1.002 | 1.001–1.004 | 0.005 | 1.02 | 0.94–1.19 | 0.944 | COMT-I use | 2.80 | 1.17–6.74 | 0.021 | 3.41 | 1.06–11.37 | 0.052 | Neuroleptic use | 12.34 | 1.48–102.98 | 0.020 | 1.25 | 0.16–12.67 | 0.854 | Cholinesterase inhibitor use | 11.92 | 2.12–12.34 | 0.002 | 1.11 | 0.23–11.78 | 0.756 |
|
|
Abbreviations. PD: Parkinson disease; UPDRS: Unified Parkinson’s Disease Rating Scale; FOG: freezing of gait; MMSE: Minimental State Examination.
* Functional tests: higher scores means normality.
|